S.1681 - A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.115th Congress (2017-2018)
|Sponsor:||Sen. Sanders, Bernard [I-VT] (Introduced 07/31/2017)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||Senate - 07/31/2017 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.1681 — 115th Congress (2017-2018)All Information (Except Text)
A summary is in progress.